Lakewood-Amedex Biotherapeutics (LABT US)

Analysis

Health Care • United States

Lakewood-Amedex Biotherapeutics Inc. operates as a clinical-stage biotechnology company. The Company focuses on the discovery and development of antimicrobial therapeutics for the treatment of infectious diseases, particularly those driven by antimicrobial resistance. Lakewood-Amedex Biotherapeutics operates in the United States.

Refresh

Exchange Announcement • 19 Sep 2026 05:30

S-1 | IPO Registration

Exchange Announcement • 18 Aug 2026 04:44

424B3 | Prospectus

Exchange Announcement • 14 Aug 2026 08:00

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 16 Jul 2026 04:15

Current Report (Form 8-K | Period ending 2026-07-15)

No more filings

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00